Immuron Ltd ADR (IMRN)

$1.78 +0.05 (2.89%)
Market Cap 10.11M
Revenue (ttm) 3.22M
Net Income (ttm) -4.55M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -141.30%
Debt to Equity Ratio 0.00
Volume 8,300
Avg Vol 30,696
Day's Range N/A - N/A
Shares Out 5.85M
Stochastic %K 48%
Beta 0.96
Analysts Strong Sell
Price Target $5.00

Company Profile

Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, the United States, and Canada. It operates through two segments, Research and Development; and Hyper-immune Products. The company offers Travelan, an over-the-counter medicine to reduce the risk of travelers' diarrhea and risk of minor gastrointestinal disorders, as well as a dietary supplement for digestive tract protection; and Protectyn, an immune su...

Industry: Biotechnology
Sector: Healthcare
Phone: 61 3 9824 5254
Fax: 61 3 9822 7735
Address:
62 Lygon Street, Level 3 Carlton South, Carlton, Australia
GreenResearchers
GreenResearchers Jun. 16 at 9:52 AM
GLMD is a powder keg ready to blow. Trading under cash with a $20+ book value, no debt, and a tiny float this isn’t just undervalued, it’s insanely mispriced. The chart is tightening, momentum is building, and massive GLP-1 obesity + fibrosis catalysts are around the corner. This sector has sent names flying 500%+… GLMD hasn’t even started. When the spark hits volume, PR, or smart money rotation this could rip like wildfire. One of the cleanest high-upside setups on the entire market right now. $ATNF, $OPGN, $ACXP, $IMRN 🌙
0 · Reply
Baseball89
Baseball89 Jun. 10 at 10:11 AM
$LAES $BURU $IMRN --a sleeper $GPUS $FAAS Way undervalued
0 · Reply
Baseball89
Baseball89 Jun. 10 at 9:36 AM
$MLGO $IMRN ---this is asleeper about to wake up
0 · Reply
twisrs
twisrs Jun. 2 at 2:24 PM
$IMRN $2 soon!
0 · Reply
Baseball89
Baseball89 Jun. 2 at 11:34 AM
$SBET $GPUS , $LAES $IMRN
0 · Reply
Baseball89
Baseball89 Jun. 2 at 9:57 AM
$BMGL $IMRN ---no reverse splits, increased corporate earnings. Looks solid. Keep on watch.
0 · Reply
delvanbeyond
delvanbeyond Jun. 1 at 1:08 PM
$IMRN 📈📈📈
0 · Reply
Baseball89
Baseball89 May. 30 at 9:47 PM
$BMGL $IMRN this one looks good. It's about to wakey wakey!!!! Put on your radar
0 · Reply
Slitherin
Slitherin May. 30 at 3:06 PM
$IMRN huge catalysts inbound . Could run like $SBET $RGC This company has never done a reverse split and has trials ongoing with the US army
0 · Reply
twisrs
twisrs May. 30 at 2:43 PM
$SBET $IMRN looking good!!
0 · Reply
Latest News on IMRN
Immuron Letter to Shareholders: Projects Update

May 30, 2025, 6:00 AM EDT - 17 days ago

Immuron Letter to Shareholders: Projects Update

Immuron Travelan® highest sales in history

Apr 10, 2025, 6:00 PM EDT - 2 months ago

Immuron Travelan® highest sales in history

Immuron and Calmino join up to treat Irritable Bowel Syndrome (IBS)

Mar 5, 2025, 6:00 AM EST - 3 months ago

Immuron and Calmino join up to treat Irritable Bowel Syndrome (IBS)

Immuron Travelan® continued strong sales growth

Jan 17, 2025, 6:00 AM EST - 5 months ago

Immuron Travelan® continued strong sales growth

Immuron Announces New Research Collaboration targeting Antimicrobial Resistance

Jan 15, 2025, 6:00 AM EST - 5 months ago

Immuron Announces New Research Collaboration targeting Antimicrobial Resistance

Immuron Announces Travelan® Clinical Trial Update

Jan 14, 2025, 6:00 AM EST - 5 months ago

Immuron Announces Travelan® Clinical Trial Update

Immuron CEO, Steven Lydeamore to Present at the Small Cap Growth Virtual Investor Conference December 5th

Dec 2, 2024, 6:00 AM EST - 7 months ago

Immuron CEO, Steven Lydeamore to Present at the Small Cap Growth Virtual Investor Conference December 5th

Immuron CEO, Steven Lydeamore presentation to 21st Virtual Investor Summit Microcap Event

Nov 21, 2024, 6:33 PM EST - 7 months ago

Immuron CEO, Steven Lydeamore presentation to 21st Virtual Investor Summit Microcap Event

Immuron Limited to Present at November 21st Virtual Investor Summit Microcap Event

Nov 18, 2024, 8:30 AM EST - 7 months ago

Immuron Limited to Present at November 21st Virtual Investor Summit Microcap Event

Immuron CEO, Steven Lydeamore participation in Maxim Virtual Healthcare Conference

Oct 16, 2024, 6:00 AM EDT - 8 months ago

Immuron CEO, Steven Lydeamore participation in Maxim Virtual Healthcare Conference

NMRC Reports Results for Campylobacter Controlled Human Infection Model Study

Oct 4, 2024, 6:30 AM EDT - 9 months ago

NMRC Reports Results for Campylobacter Controlled Human Infection Model Study

Traveler's Diarrhea Therapeutics Pipeline Market Report 2024 Featuring Immuron, Scandinavian Biopharma, and Sigmoid Pharma

Sep 19, 2024, 9:42 AM EDT - 9 months ago

Traveler's Diarrhea Therapeutics Pipeline Market Report 2024 Featuring Immuron, Scandinavian Biopharma, and Sigmoid Pharma

Immuron Plans Phase 2 Trial for IMM-529 following FDA review

Sep 5, 2024, 11:54 AM EDT - 10 months ago

Immuron Plans Phase 2 Trial for IMM-529 following FDA review

Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now

Aug 20, 2024, 7:00 AM EDT - 10 months ago

Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now

CIA CVKD ELUT EUDA GDTC GOSS GOVX

Immuron Announces New U.S. Department of Defense Research Award for Naval Medical Research Command and Walter Reed Army Institute of Research to advance Travelan®

Aug 16, 2024, 6:00 AM EDT - 10 months ago

Immuron Announces New U.S. Department of Defense Research Award for Naval Medical Research Command and Walter Reed Army Institute of Research to advance Travelan®

Immuron CEO, Steven Lydeamore to present at the Emerging Growth Conference

Aug 15, 2024, 6:14 PM EDT - 10 months ago

Immuron CEO, Steven Lydeamore to present at the Emerging Growth Conference

Immuron CEO, Steven Lydeamore to host webinar on MarketOpen Direct Connect

Aug 7, 2024, 6:00 AM EDT - 11 months ago

Immuron CEO, Steven Lydeamore to host webinar on MarketOpen Direct Connect

Immuron requests pre-IND meeting for IMM-529 with FDA filing

Jul 2, 2024, 6:00 AM EDT - 1 year ago

Immuron requests pre-IND meeting for IMM-529 with FDA filing

Immuron Board Changes

May 31, 2024, 6:00 AM EDT - 1 year ago

Immuron Board Changes

Immuron CEO Steven Lydeamore to present at Peak Sky High

May 31, 2024, 6:00 AM EDT - 1 year ago

Immuron CEO Steven Lydeamore to present at Peak Sky High

Immuron Limited to Present at the Emerging Growth Conference

May 7, 2024, 6:00 AM EDT - 1 year ago

Immuron Limited to Present at the Emerging Growth Conference

Immuron Director Resignation

May 3, 2024, 6:00 AM EDT - 1 year ago

Immuron Director Resignation

Immuron to host Live Virtual Event

Apr 15, 2024, 6:00 AM EDT - 1 year ago

Immuron to host Live Virtual Event

Immuron Travelan® sales continued strong growth

Apr 10, 2024, 6:00 AM EDT - 1 year ago

Immuron Travelan® sales continued strong growth

Immuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the US

Mar 7, 2024, 6:00 AM EST - 1 year ago

Immuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the US

Immuron Presentation Australian Biologics Festival 2024

Feb 21, 2024, 6:00 AM EST - 1 year ago

Immuron Presentation Australian Biologics Festival 2024

Immuron achieves record Travelan® sales

Feb 13, 2024, 6:00 AM EST - 1 year ago

Immuron achieves record Travelan® sales

Immuron CEO, Steven Lydeamore Investor Webinar Presentation

Feb 8, 2024, 6:00 AM EST - 1 year ago

Immuron CEO, Steven Lydeamore Investor Webinar Presentation

Immuron achieves record half yearly Travelan® sales

Jan 16, 2024, 6:00 AM EST - 1 year ago

Immuron achieves record half yearly Travelan® sales

Immuron Clinical Trials Update

Dec 22, 2023, 6:00 AM EST - 1 year ago

Immuron Clinical Trials Update

Immuron Announces First Patients Enrolled in Campylobacter Challenge Clinical Study

Dec 4, 2023, 6:00 AM EST - 1 year ago

Immuron Announces First Patients Enrolled in Campylobacter Challenge Clinical Study

Immuron CEO Steven Lydeamore Investor Webinar Presentation

Nov 13, 2023, 6:00 PM EST - 1 year ago

Immuron CEO Steven Lydeamore Investor Webinar Presentation

Immuron CEO Steven Lydeamore presented at AusBioInvest

Oct 30, 2023, 7:21 AM EDT - 1 year ago

Immuron CEO Steven Lydeamore presented at AusBioInvest

Immuron Announces Travelan® Clinical Study Cohort 2 commences

Oct 18, 2023, 6:00 AM EDT - 1 year ago

Immuron Announces Travelan® Clinical Study Cohort 2 commences

Immuron achieves record quarterly Travelan® sales

Oct 11, 2023, 6:00 AM EDT - 1 year ago

Immuron achieves record quarterly Travelan® sales

Immuron Limited Announces Participation in the LD Micro Main Event XVI

Sep 18, 2023, 7:30 AM EDT - 1 year ago

Immuron Limited Announces Participation in the LD Micro Main Event XVI

Immuron achieves record monthly Travelan® sales

Sep 13, 2023, 6:00 AM EDT - 1 year ago

Immuron achieves record monthly Travelan® sales

Immuron CEO, Steven Lydeamore to present at H.C. Wainwright

Sep 11, 2023, 6:00 AM EDT - 1 year ago

Immuron CEO, Steven Lydeamore to present at H.C. Wainwright

Immuron to present at the Military Health System Research Symposium

Aug 14, 2023, 6:00 AM EDT - 2 years ago

Immuron to present at the Military Health System Research Symposium

Immuron Announces First Patients Enrolled in Travelan® Clinical Study

Jul 25, 2023, 6:00 AM EDT - 2 years ago

Immuron Announces First Patients Enrolled in Travelan® Clinical Study

Immuron CEO, Steven Lydeamore to present at Bioshares

Jul 24, 2023, 6:00 AM EDT - 2 years ago

Immuron CEO, Steven Lydeamore to present at Bioshares

Immuron Business Update - Ateria Health launches Juvia™ in Australia

Jul 11, 2023, 6:00 AM EDT - 2 years ago

Immuron Business Update - Ateria Health launches Juvia™ in Australia

Immuron FY23 Sales increase 136% on FY22 Sales

Jul 5, 2023, 6:00 AM EDT - 2 years ago

Immuron FY23 Sales increase 136% on FY22 Sales

Immuron Chairman Transition

Jun 30, 2023, 6:00 AM EDT - 2 years ago

Immuron Chairman Transition

Immuron Business Update: Letter to Shareholders

Jun 22, 2023, 6:00 AM EDT - 2 years ago

Immuron Business Update: Letter to Shareholders

Immuron Initiates Recruitment of Travelan® Clinical Study

May 30, 2023, 6:00 AM EDT - 2 years ago

Immuron Initiates Recruitment of Travelan® Clinical Study

Immuron Limited Announces Participation in the LD Micro Invitational XIII

May 16, 2023, 7:30 AM EDT - 2 years ago

Immuron Limited Announces Participation in the LD Micro Invitational XIII

Immuron stock rockets after FDA removes hold on IND of infectious diarrhea treatment

May 8, 2023, 6:35 AM EDT - 2 years ago

Immuron stock rockets after FDA removes hold on IND of infectious diarrhea treatment

Immuron Announces FDA Removed Clinical Hold on New Campylobacter ETEC Therapeutic Paves way for Clinical Trial Initiation

May 8, 2023, 6:00 AM EDT - 2 years ago

Immuron Announces FDA Removed Clinical Hold on New Campylobacter ETEC Therapeutic Paves way for Clinical Trial Initiation

Immuron CEO, Steven Lydeamore to present at Coffee Microcaps

May 2, 2023, 6:00 AM EDT - 2 years ago

Immuron CEO, Steven Lydeamore to present at Coffee Microcaps

GreenResearchers
GreenResearchers Jun. 16 at 9:52 AM
GLMD is a powder keg ready to blow. Trading under cash with a $20+ book value, no debt, and a tiny float this isn’t just undervalued, it’s insanely mispriced. The chart is tightening, momentum is building, and massive GLP-1 obesity + fibrosis catalysts are around the corner. This sector has sent names flying 500%+… GLMD hasn’t even started. When the spark hits volume, PR, or smart money rotation this could rip like wildfire. One of the cleanest high-upside setups on the entire market right now. $ATNF, $OPGN, $ACXP, $IMRN 🌙
0 · Reply
Baseball89
Baseball89 Jun. 10 at 10:11 AM
$LAES $BURU $IMRN --a sleeper $GPUS $FAAS Way undervalued
0 · Reply
Baseball89
Baseball89 Jun. 10 at 9:36 AM
$MLGO $IMRN ---this is asleeper about to wake up
0 · Reply
twisrs
twisrs Jun. 2 at 2:24 PM
$IMRN $2 soon!
0 · Reply
Baseball89
Baseball89 Jun. 2 at 11:34 AM
$SBET $GPUS , $LAES $IMRN
0 · Reply
Baseball89
Baseball89 Jun. 2 at 9:57 AM
$BMGL $IMRN ---no reverse splits, increased corporate earnings. Looks solid. Keep on watch.
0 · Reply
delvanbeyond
delvanbeyond Jun. 1 at 1:08 PM
$IMRN 📈📈📈
0 · Reply
Baseball89
Baseball89 May. 30 at 9:47 PM
$BMGL $IMRN this one looks good. It's about to wakey wakey!!!! Put on your radar
0 · Reply
Slitherin
Slitherin May. 30 at 3:06 PM
$IMRN huge catalysts inbound . Could run like $SBET $RGC This company has never done a reverse split and has trials ongoing with the US army
0 · Reply
twisrs
twisrs May. 30 at 2:43 PM
$SBET $IMRN looking good!!
0 · Reply
XkaliburTrading
XkaliburTrading May. 30 at 2:05 PM
$IMRN Ok ok Shorts Availability 100.00K Cost To Borrow 42.16% Short Interest 0.21%
0 · Reply
6k_investor
6k_investor May. 30 at 2:04 PM
$IMRN Top line results from their clinical trial with Travelan expected in October with multiple catalysts in August. Low dilution risk and they have cash 💰
0 · Reply
ahTony
ahTony May. 29 at 11:43 PM
$IMRN
0 · Reply
HFlier
HFlier May. 29 at 6:00 PM
$IMRN Boom, the book wasn't wrong today.
1 · Reply
Moneyyx
Moneyyx May. 29 at 2:09 AM
$IMRN anyone have any updates on earnings ?
0 · Reply
twisrs
twisrs May. 27 at 7:03 PM
$SBET $IMRN
0 · Reply
frankyboyz
frankyboyz May. 27 at 4:48 PM
$IMRN ER before market open tomorrow
2 · Reply
Baseball89
Baseball89 May. 23 at 2:59 PM
$IMRN Buy and Hold
0 · Reply
marione
marione May. 23 at 2:57 PM
$SYTA $AAPL $IMRN $SYTASIYATA mobile ready to explode and see it at $70 IT'S ABOUT TO BE EPIC TA
0 · Reply
delvanbeyond
delvanbeyond May. 23 at 4:11 AM
$NVDA $IMRN so many catalyst
0 · Reply
Baseball89
Baseball89 May. 22 at 11:36 PM
$IMRN way undervalued. No dilution. Good catalyst. Strong sales have increased and doubled year after year. 2+ soon. Let's go!
0 · Reply
frankyboyz
frankyboyz May. 22 at 8:52 PM
$IMRN holding on to tomorrow... and prolly beyond... let's see $IMRN good night fam, see you premarket
0 · Reply